Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal cell carcinoma

P D Savage1

  • 1Comprehensive Cancer Center, Wake Forest University, Bowman Gray School of Medicine, Winston-Salem, NC 27157-1082.

Current Opinion in Oncology
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Recent advancements in renal cell carcinoma research have clarified the immune system's role and identified new biomarkers. This progress offers hope for more targeted and effective treatments for advanced kidney cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaporation-induced foam stabilization in lubricating oils.

Proceedings of the National Academy of Sciences of the United States of America·2018
Same author

The safety and efficacy of early-initiation exercise training after acute venous thromboembolism: a randomized clinical trial.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Development of a quantitative real-time PCR for the detection of Tenacibaculum maritimum and its application to field samples.

Journal of fish diseases·2012
Same author

The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.

International journal of obesity (2005)·2008
Same author

Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec.

Abdominal imaging·2004
Same author

Medical management of metastatic skeletal disease.

The Orthopedic clinics of North America·2000
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Renal cell carcinoma (RCC) research has seen significant progress over the past year.
  • Understanding the complex interplay between the immune system and RCC is crucial for developing new therapies.

Purpose of the Study:

  • To summarize recent advancements in understanding renal cell carcinoma.
  • To highlight progress in immunomodulatory therapies and biomarker discovery for RCC.

Main Methods:

  • Review of recent scientific literature on renal cell carcinoma.
  • Analysis of studies focusing on immune system interactions, biomarkers, and molecular aspects of RCC.

Main Results:

  • Improved understanding of interferons and interleukins in RCC treatment, including patient selection.

Related Experiment Videos

  • Discovery of novel biologic markers with potential prognostic and therapeutic value.
  • Advancements in comprehending the molecular underpinnings of RCC.

    • Conclusions:

    • Recent progress enhances the understanding of immune system roles and biomarkers in renal cell carcinoma.
    • These advancements pave the way for more targeted, less toxic, and effective treatments for advanced RCC.